文献速递骨肌MR

MRI预测模型用于弥漫型腱鞘巨细胞瘤风险判断

MRI Prediction Model for Tenosynovial Giant Cell Tumor with Risk of Diffuse-type.
PubMed 文献 · Acad Radiol · 2023-02-06

该研究基于MRI特征构建预测模型,用于区分弥漫型与局限型腱鞘巨细胞瘤。关节外弥漫型更常见多结节、浸润性、无周边低信号、颗粒状内部低信号及骨软骨受累;关节内弥漫型除骨受累外其余特征均有显著差异。以软骨受累起始的MRI模型对关节内和关节外弥漫型的敏感度均为100%,特异度分别为90.9%和77.2%。

要点

  • 关节外弥漫型TSGCT多见多结节、浸润性边缘、无周边低信号及颗粒状内部低信号。
  • 软骨受累对弥漫型特异度最高(88.6–100.0%),无论关节内或关节外。
  • MRI模型以软骨受累起始,关节内和关节外弥漫型敏感度均达100%。

关键影像表现/征象

  • 关节外弥漫型较局限型更常见多结节(72.7% vs. 25.0%,p=0.009)和浸润性病变(90.9% vs. 34.1%,p=0.002)。
  • 关节外弥漫型更常见无周边低信号(90.9% vs. 18.2%,p<0.001)和颗粒状内部低信号(72.7% vs. 31.8%,p=0.003)。
  • 关节外弥漫型更常见骨受累(81.8% vs. 27.3%,p=0.003)和软骨受累(50.0% vs. 0.0%,p=0.038)。
  • 关节内弥漫型所有MRI特征均有显著差异(p=0.001–0.038),除骨受累(37.5% vs. 9.1%,p=0.352)。

诊断标准与关键数值

  • 软骨受累对弥漫型特异度最高(88.6–100.0%),不受解剖位置影响。
  • 关节内弥漫型中结节性敏感度100.0%,OR=70.000。
  • 关节外弥漫型中无周边低信号敏感度90.9%,OR=62.250。
  • MRI模型(以软骨受累起始,关节内继以结节性、关节外继以无周边低信号)对关节内弥漫型敏感度100%、特异度90.9%,对关节外弥漫型敏感度100%、特异度77.2%。

临床应用与阅片要点

  • 阅片时注意评估多结节、浸润性边缘、周边低信号缺失、内部颗粒状低信号及骨软骨受累。
  • 关节内病变重点观察结节性,关节外病变重点观察周边低信号是否缺失。
  • 软骨受累可作为提示弥漫型的高特异度征象。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

RATIONALE AND OBJECTIVES: To propose a magnetic resonance imaging (MRI) prediction model for diffuse-type tenosynovial giant cell tumors (D-TSGCTs).

MATERIALS AND METHODS: Anatomic locations were classified and then nodularity, margin, peripheral and internal hypointensity, and bone and cartilage involvement were evaluated on MRI. Student's t-test, chi-square test, diagnostic performance, logistic regression analysis, and decision tree were performed.

RESULTS: Nineteen intra-articular (11 localized; eight diffuse) and 55 extra-articular (44 localized; 11 diffuse) TSGCTs were included. Extra-articular D-TSGCTs showed significantly more frequent multinodular (72.7% vs. 25.0%, p = 0.009), and infiltrative lesions (90.9% vs. 34.1%, p = 0.002), without peripheral hypointensity (90.9% vs. 18.2%, p < 0.001), and contained granular internal hypointensity (72.7% vs. 31.8%; p = 0.003) with more frequent bone (81.8% vs. 27.3%; p = 0.003) and cartilage (50.0% vs. 0.0%; p = 0.038) involvement than localized-type. Intra-articular D-TSGCT also showed significance in all MRI features (100.0% vs. 9.1%, p = 0.001; 100.0% vs. 27.3%, p = 0.007; 100.0% vs. 36.4%, p = 0.018; 100.0% vs. 27.3%, p = 0.007; 50.0% vs. 0.0%, p = 0.038), except bone involvement (37.5% vs. 9.1%, p = 0.352) than localized-type. Cartilage involvement revealed the highest specificity (88.6-100.0%), regardless of location. Nodularity (100.0%; odds-ratio [OR]: 70.000) and peripheral hypointensity (90.9%; OR: 62.250) demonstrated the highest sensitivities ORs for D-TSGCT in intra-articular and extra-articular cases, respectively. MRI models for D-TSGCG beginning with the cartilage involvement in both anatomic locations and next on nodularity and peripheral hypointensity in intra-articular and extra-articular locations, respectively, exhibited sensitivity and specificity of 100% and 90.9% for intra-articular and 100% and 77.2% for extra-articular TSGCTs, respectively.

CONCLUSION: MRI can suggest the risk of D-TSGCT by combining imaging features with anatomic locations.

来源:Acad Radiol,查看原文。版权归原作者所有。

引用

  1. Kim, Lee, Kim, et al. MRI Prediction Model for Tenosynovial Giant Cell Tumor with Risk of Diffuse-type. Acad Radiol. 2023. PMID: 36754646. doi:10.1016/j.acra.2023.01.012

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。